ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Dermata Therapeutics Inc

Dermata Therapeutics Inc (DRMA)

3.38
-0.0983
(-2.83%)
Closed May 26 4:00PM
3.38
0.00
(0.00%)
After Hours: 6:22PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
3.38
Bid
3.31
Ask
3.45
Volume
19,942
3.3601 Day's Range 3.5299
0.232 52 Week Range 5.79
Market Cap
Previous Close
3.4783
Open
3.44
Last Trade
1
@
3.45
Last Trade Time
Financial Volume
$ 68,294
VWAP
3.4246
Average Volume (3m)
115,627
Shares Outstanding
3,189,034
Dividend Yield
-
PE Ratio
-1.38
Earnings Per Share (EPS)
-2.44
Revenue
-
Net Profit
-7.8M

About Dermata Therapeutics Inc

Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its p... Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Dermata Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DRMA. The last closing price for Dermata Therapeutics was $3.48. Over the last year, Dermata Therapeutics shares have traded in a share price range of $ 0.232 to $ 5.79.

Dermata Therapeutics currently has 3,189,034 shares outstanding. The market capitalization of Dermata Therapeutics is $10.78 million. Dermata Therapeutics has a price to earnings ratio (PE ratio) of -1.38.

DRMA Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.12-24.88888888894.553.24797293.59495108CS
43.034876.8786127170.3465.790.3116746861.64629102CS
122.9176630.9688581310.46245.790.2321156270.62328909CS
262.6761380.1818440120.70395.790.2324535560.62646979CS
521.1551.56950672652.235.790.2323401310.8056658CS
156-89.42-96.357758620792.8111.20.2328167419.92555816CS
260-89.42-96.357758620792.8111.20.2328167419.92555816CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LUCYInnovative Eyewear Inc
$ 0.983
(428.49%)
944.4M
AKANAkanda Corporation
$ 4.07
(70.29%)
39.11M
TKLFYoshitsu Company Ltd
$ 0.3496
(53.33%)
84.5M
ONMDOneMedNet Corporation
$ 2.251
(53.13%)
136.04M
MRUSMerus NV
$ 59.92
(35.97%)
6.91M
VSTMVerastem Inc
$ 4.0901
(-66.42%)
19.68M
TOIIWOncology Institute Inc
$ 0.0443
(-55.61%)
280.55k
SNSESensei Biotherapeutics Inc
$ 0.7912
(-45.43%)
1.41M
GNLXGenelux Corporation
$ 2.61
(-43.26%)
3.32M
AUVIApplied UV Inc
$ 0.32
(-33.33%)
5.18M
LUCYInnovative Eyewear Inc
$ 0.983
(428.49%)
944.4M
GWAVGreenwave Technology Solutions Inc
$ 0.0843
(-4.85%)
428.98M
NCPLNetcapital Inc
$ 0.20
(14.42%)
191.35M
HLTHCue Health Inc
$ 0.0931
(-1.27%)
160.21M
ONMDOneMedNet Corporation
$ 2.251
(53.13%)
136.04M

DRMA Discussion

View Posts
tw0122 tw0122 1 week ago
Reverse split completed watch for new bottom
👍️0
Monksdream Monksdream 1 month ago
DRMA new 52 lo
👍️0
glenn1919 glenn1919 2 months ago
DRMA...............................https://stockcharts.com/h-sc/ui?s=DRMA&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 3 months ago
DRMA10QnduebMarchb6
👍️0
glenn1919 glenn1919 5 months ago
DRMA.................................https://stockcharts.com/h-sc/ui?s=DRMA&p=W&b=5&g=0&id=p86431144783
👍️0
Zorro Zorro 5 months ago
Might have a good AH again.
👍️0
Invest-in-America Invest-in-America 5 months ago
DRMA: And when all is said & done, a classic TOILET FLUSH!!! (Heck with this shit, I'm goin' back to Vegas!!)
👍️0
Pnypnchr Pnypnchr 5 months ago
Yep I'm well. Same to you as well.

Gonna try to jump in here in the AM if it don't get too far gone.
👍️0
subslover subslover 5 months ago
Thank you, buddy! Hope you're doing well and happy new year!
👍️0
Pnypnchr Pnypnchr 5 months ago
Absolutely, nice move here.
👍️0
subslover subslover 5 months ago
Win or loose I had to take a shot. You know me well lol
👍️0
TheFinalCD TheFinalCD 5 months ago
NICE BUYS, BETTER LATE THAN NEVER
👍️0
subslover subslover 5 months ago
Zorro just filled at $1.12 now gonna sleep on it lol
👍️0
subslover subslover 5 months ago
Nothing makes sense anymore! Most of the Pink Sheets have no liquidity anymore. This BS on the NASDAQ is the only game of chance lol
👍️0
subslover subslover 5 months ago
I'm jumping in now
👍️0
Zorro Zorro 5 months ago
Must be time to buy:
https://www.barchart.com/stocks/quotes/DRMA/opinion
👍️0
TheFinalCD TheFinalCD 5 months ago
GOOD ALERT ON NEWS, THE CHART IS A PRIME EXAMPLE OF HOW CRAZY THIS MARKET REALLY IS

https://finviz.com/quote.ashx?t=DRMA&ty=c&ta=1&p=d
👍️0
Zorro Zorro 5 months ago
Nice catch!
👍️0
Zorro Zorro 5 months ago
Lol! Scared money doesn't make any. Sometimes you just have to go with your instincts.
👍️0
Invest-in-America Invest-in-America 5 months ago
DRMAW (Warrants): Closed UP by 153% today in the OPEN Market --- before the Post-M news even hit (Insiders at work).
👍️0
subslover subslover 5 months ago
I have to think a good chunk of that 7 million offering got bought. I'm thinking about taking a slice on a dip because IMHO this could fly past $2.00 tomorrow. Total game of craps but I'm a compulsive gambler :)
👍️0
Zorro Zorro 5 months ago
Always the guess with AH. Dang MM like to play early PM.
👍️0
subslover subslover 5 months ago
This baby is flying to new heights! Will be interesting how she does tomorrow
👍️0
Zorro Zorro 5 months ago
Might have more gas in the tank.
👍️0
Zorro Zorro 5 months ago
Made some nice money on the warrants if they sold.
👍️0
subslover subslover 5 months ago
Here you go, buddy https://www.otcmarkets.com/filing/html?id=17107805&guid=eyJ-kpcUPOVAB3h
👍️0
Zorro Zorro 5 months ago
Thanks! At what price if you know. OVER 7m just traded.
👍️0
subslover subslover 5 months ago
I used to trade this one. Haven't seen it in a while. There is an offering for 7.1 million shares
👍️0
Zorro Zorro 5 months ago
Was wondering why it was moving. Low floater 3.54M worth keeping an eye on.. Thanks for posting.
👍️0
subslover subslover 5 months ago
NEWS
Dermata Expands Global Intellectual Patent Portfolio with Issuance of Japanese Patent for DMT410 for the Treatment of Hyperhidrosis
- This is the Company's first patent issued for DMT410, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis -
- The Company is currently discussing partnership opportunities to advance development of DMT410 -
- In 2022, the Japanese prevalence of hyperhidrosis was 10%, with approximately 6% having primary axillary hyperhidrosis -

SAN DIEGO, CA / ACCESSWIRE / January 4, 2024 / Dermata Therapeutics, Inc. (Nasdaq:DRMA, DRMAW) ("Dermata" or the "Company"), a late-stage biotechnology company focusing on the treatment of medical and aesthetic skin conditions, today announced the issuance of a new patent in Japan for its DMT410 program for the treatment of hyperhidrosis. The patent, entitled "Compositions for the treatment of skin conditions," (Japanese Patent No. 7395576) further strengthens Dermata's intellectual property for DMT410 for the treatment of hyperhidrosis and could lead to further protections for additional indications.

"We believe this patent issuance further validates DMT410's novel concept to easily deliver botulinum toxin topically instead of requiring patients to receive multiple injections," says Gerry Proehl, Dermata's Chairman, President, and CEO. "We are excited about the opportunities the DMT410 program can bring to patients, not only for the treatment of axillary hyperhidrosis as we have seen in our proof-of-concept study, but potentially for palmer and plantar hyperhidrosis which has no currently approved products. We also believe there are opportunities to use DMT410 to treat many aesthetic skin conditions like reducing pore number and size, decreasing sebum production, and reducing fine lines and wrinkles, all while improving the look and quality of facial skin," continued Mr. Proehl. "We also believe this new patent could aid us in our partnership discussions with a company that has a botulinum toxin to further develop the DMT410 program for multiple indications."

About DMT410
👍️0
$oldier Hard $oldier Hard 5 months ago
$DRMA rolling in A/Hs.
👍️0
mick mick 5 months ago
https://www.otcmarkets.com/stock/DRMA
👍️0
tw0122 tw0122 6 months ago
Flying to $1.10 back to .70s back to .80s has volume
👍️0
$oldier Hard $oldier Hard 7 months ago
Gap filled from this mornings opening and may be consolidating now.
👍️0
mick mick 7 months ago
https://www.otcmarkets.com/stock/DRMA
👍️0
glenn1919 glenn1919 7 months ago
DRMA................................https://stockcharts.com/h-sc/ui?s=DRMA&p=W&b=5&g=0&id=p86431144783
👍️0
$oldier Hard $oldier Hard 7 months ago
$DRMA low floater 2.9 mil, heavily oversold, might have to start buying a few of this one.
👍️0
Monksdream Monksdream 7 months ago
DRMA new 52 week low
👍️0
Monksdream Monksdream 7 months ago
DRMA new 52 wewek low
👍️0
Monksdream Monksdream 8 months ago
DRMA under $2
👍️0
mick mick 8 months ago
https://www.otcmarkets.com/stock/DRMA
👍️0
mick mick 9 months ago
$drma Recent DRMA News
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:18:20 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:16:30 PM
👍️0
mick mick 9 months ago
$drma
Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 08:31:21 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/28/2023 04:15:22 AM
👍️0
mick mick 9 months ago
$DRMA Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 07/27/2023 08:50:42 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/07/2023 08:21:18 PM
👍️0
mick mick 9 months ago
nice chart
https://stockcharts.com/c-sc/sc?s=DRMA&p=D&yr=1&mn=1&dy=0&i=p24986097784&a=1113701411&r=1693595168175
👍️0
The Night Stalker The Night Stalker 11 months ago
good news and it goes red
👍️0
The Night Stalker The Night Stalker 11 months ago
good news and it goes red
👍️0
The Night Stalker The Night Stalker 11 months ago
https://www.otcmarkets.com/stock/DRMA/news/story?e&id=2564690
👍️0
tw0122 tw0122 11 months ago
Run run $1.90s
👍️0
The Night Stalker The Night Stalker 11 months ago
https://stockcharts.com/h-sc/ui?s=drma&p=D&yr=1&mn=1&dy=0&id=p24986097784&listNum=23&a=1113701411
👍️0

Your Recent History

Delayed Upgrade Clock